Concepedia

Işıl Altıntaş

IA

Statistics

Publications

2

Citations

214

H-Index

2

Active since

2018

Affiliations

Inserm(Current)

Işıl Altıntaş is an author at Inserm specializing in immunology, cancer research, and oncology.

Top concepts

Publications per year

2018–2024

2

Publications

2

Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study

Kim Linton, Umberto Vitolo, Wojciech Jurczak et al. · The Lancet Haematology · 2024 · 111 citations · Full text

, , +8

CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory

Hreinn Benonisson, Işıl Altıntaş, Marjolein Sluijter et al. · Molecular Cancer Therapeutics · 2018 · 103 citations

1–2 of 2